792 related articles for article (PubMed ID: 16249495)
1. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
5. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
Levkovitch-Verbin H; Quigley HA; Martin KR; Valenta D; Baumrind LA; Pease ME
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):402-10. PubMed ID: 11818384
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat.
Lau J; Dang M; Hockmann K; Ball AK
Exp Eye Res; 2006 Jan; 82(1):132-45. PubMed ID: 16045909
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
10. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
Naskar R; Wissing M; Thanos S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
[TBL] [Abstract][Full Text] [Related]
11. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
12. Optic nerve and neuroprotection strategies.
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131
[TBL] [Abstract][Full Text] [Related]
14. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
15. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
Mittag TW; Danias J; Pohorenec G; Yuan HM; Burakgazi E; Chalmers-Redman R; Podos SM; Tatton WG
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
[TBL] [Abstract][Full Text] [Related]
16. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
[TBL] [Abstract][Full Text] [Related]
17. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
Thanos S; Naskar R
Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
[TBL] [Abstract][Full Text] [Related]
18. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
[TBL] [Abstract][Full Text] [Related]
19. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
Urcola JH; Hernández M; Vecino E
Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
[TBL] [Abstract][Full Text] [Related]
20. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys.
Hayreh SS; Pe'er J; Zimmerman MB
J Glaucoma; 1999 Feb; 8(1):56-71. PubMed ID: 10084276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
